Spiro Rombotis
2019
In 2019, Spiro Rombotis earned a total compensation of $1M as President and Chief Executive Officer at Cyclacel Pharmaceuticals, a 35% increase compared to previous year.
Compensation breakdown
| Bonus | $159,166 |
|---|---|
| Option Awards | $285,671 |
| Salary | $530,553 |
| Other | $39,081 |
| Total | $1,014,471 |
Rombotis received $530.6K in salary, accounting for 52% of the total pay in 2019.
Rombotis also received $159.2K in bonus, $285.7K in option awards and $39.1K in other compensation.
Rankings
In 2019, Spiro Rombotis' compensation ranked 9,197th out of 13,971 executives tracked by ExecPay. In other words, Rombotis earned more than 34.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,197 out of 13,971 | 34th |
Division Manufacturing | 3,685 out of 5,698 | 35th |
Major group Chemicals And Allied Products | 1,397 out of 2,197 | 36th |
Industry group Drugs | 1,191 out of 1,883 | 37th |
Industry Pharmaceutical Preparations | 884 out of 1,395 | 37th |
Source: SEC filing on May 12, 2020.
Rombotis' colleagues
We found two more compensation records of executives who worked with Spiro Rombotis at Cyclacel Pharmaceuticals in 2019.
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020